|
Antiplatelets
Citations 61-70 of 92 total displayed.
|
Past content
(since Mar 2000):
|
- Clinical Investigations and Reports
Randomized, Double-Blind, Placebo-Controlled, International Trial of the Oral IIb/IIIa Antagonist Lotrafiban in Coronary and Cerebrovascular Disease
- Eric J. Topol, Donald Easton, Robert A. Harrington, Pierre Amarenco, Robert M. Califf, Carmen Graffagnino, Stephen Davis, Hans-Christophe Diener, James Ferguson, Desmond Fitzgerald, Jeffrey Granett, Ashfaq Shuaib, Peter J. Koudstaal, Pierre Theroux, Frans Van de Werf, Kristina Sigmon, Karen Pieper, Marc Vallee, and James T. Willerson
Circulation published July 21, 2003, doi:10.1161/01.CIR.0000084501.48570.F6
[Abstract]
[Full text]
- Articles
Functional and Biochemical Evaluation of Platelet Aspirin Resistance After Coronary Artery Bypass Surgery
- N. Zimmermann, A. Wenk, U. Kim, P. Kienzle, A. -A. Weber, E. Gams, K. Schrör, and T. Hohlfeld
Circulation published July 21, 2003, doi:10.1161/01.CIR.0000081770.51929.5A
[Abstract]
- Clinical Investigations and Reports
Prognostic Value of Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 994 Patients With Nonvalvular Atrial Fibrillation
- Dwayne S.G. Conway, Lesly A. Pearce, Bernard S.P. Chin, Robert G. Hart, and Gregory Y.H. Lip
Circulation 2003;107:3141-3145; published online before print as doi:10.1161/01.CIR.0000077912.12202.FC
[Abstract]
[Full text]
- Editorials
Adding to the Effectiveness of Intravenous Tissue Plasminogen Activator for Treating Acute Stroke
- James C. Grotta
Circulation 2003;107:2769-2770, doi:10.1161/01.CIR.0000069565.43766.ED
[Full text]
- Clinical Investigations and Reports
Prognostic Value of Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 994 Patients With Nonvalvular Atrial Fibrillation
- Dwayne S.G. Conway, Lesly A. Pearce, Bernard S.P. Chin, Robert G. Hart, and Gregory Y.H. Lip
Circulation published June 9, 2003, doi:10.1161/01.CIR.0000077912.12202.FC
[Abstract]
[Full text]
- Clinical Investigations and Reports
Cerebral Microembolism Is Blocked by Tirofiban, a Selective Nonpeptide Platelet Glycoprotein IIb/IIIa Receptor Antagonist
- Ulrich Junghans and Mario Siebler
Circulation 2003;107:2717-2721; published online before print as doi:10.1161/01.CIR.0000070544.15890.0E
[Abstract]
[Full text]
- Articles
Cerebral Microembolism Is Blocked by Tirofiban, a Selective Nonpeptide Platelet Glycoprotein IIb/IIIa Receptor Antagonist
- Ulrich Junghans and Mario Siebler
Circulation published May 12, 2003, doi:10.1161/01.CIR.0000070544.15890.0E
[Abstract]
- Correspondence
Patent Foramen Ovale and Cryptogenic Stroke: The Controversy Continues • Response
- David James McGaw, Antony Marcello Ugoni, Shunichi Homma, Robert R. Sciacca, Marco R. Di Tullio, John L. Thompson, Bruce Levin, Ralph L. Sacco, and J.P. Mohr
Circulation 2003;107:e51, doi:10.1161/01.CIR.0000055540.22976.6C
[Full text]
- Clinical Investigations and Reports
Modulation of Aspirin-Insensitive Eicosanoid Biosynthesis by 6-Methylprednisolone in Unstable Angina
- Francesco Cipollone, Antonina Ganci, Anita Greco, Maria Rosaria Panara, Massimo Pasquale, Domenico Di Gregorio, Ettore Porreca, Andrea Mezzetti, Franco Cuccurullo, and Paola Patrignani
Circulation 2003;107:55-61; published online before print as doi:10.1161/01.CIR.0000043260.82447.62
[Abstract]
[Full text]
- Clinical Investigations and Reports
S-Nitrosoglutathione Reduces Asymptomatic Embolization After Carotid Angioplasty
- Zoltan Kaposzta, Andrew Clifton, Jane Molloy, John F. Martin, and Hugh S. Markus
Circulation 2002;106:3057-3062; published online before print as doi:10.1161/01.CIR.0000041251.07332.28
[Abstract]
[Full text]
|
|
